Austin Westerling

Partner at Granite Point Capital

Greater Boston

Overview 

Austin Westerling is a Partner at Granite Point Capital in Greater Boston, with a background in marketing, corporate development, venture capital, and strategic partnerships. His career highlights include serving as an investor at Route and Divvy | Inc., as well as being a board member at Teikametrics and investing in companies like Acreage Holdings and Tilray.

Work Experience 

Granite Point Capital

  • Partner

    2012 - Current

    Long / short public hedge and venture capital funds

R

Route

  • Investor

    2022

    Series B investor in e-commerce business revolutionizing the post purchase experience.

Route is a software company that develops application to track and protect logistics and freight services.

Raised $288,529,839.00 from Jaws Ventures, Hanaco Venture Capital, Granger Management LLC and Madrona.

route.com
D|

Divvy | Inc.

  • Investor

    2020

    Series C investor in spend and expense management software platform. Acquired by Bill.com (NYSE: BILL) for $2.5B.

Receptor Life Sciences, Inc.

  • Investor

    2018

    Series A investor in pharmaceutical start-up developing therapies for central nervous system disorders using FDA-approved drug delivery technologies

AH

Acreage Holdings

  • Investor

    2018

    Series C investor in one of the leading US multi-state operators in medical cannabis prior to IPO (ticker: ACRG). Pending acquisition by Canopy Growth (ticker: CGC) for $3.4B.

T

Teikametrics

  • Board Member

    2018

    Seed and lead Series A investor / director in SaaS business enabling direct-to-consumer brands to accelerate revenue growth and optimize profitability

Teikametrics is an e-commerce optimization platform designed for retailers on online marketplaces.

Raised $65,000,000.00 from Granite Point Capital, Jump Capital, Jacket River, Centana Growth Partners, Lydia Jett, GoDaddy and Intel Capital.

teikametrics.com

Cerebral Therapeutics, Inc.

  • Investor

    2018

    Series A investor in clinical stage pharma company dedicated to improving the lives of patients living with uncontrolled neurological diseases with an initial focus on refractory epilepsy

TB

Tevard Biosciences

  • Investor

    2018

    Seed investor in MIT start-up pioneering tRNA-based gene therapies to treat severe genetic diseases not amenable to traditional types of gene therapy.

T

Tilray

  • Investor

    2017

    Series A investor in one of leading global medical cannabis companies (Nasdaq: TLRY)

P&

Papa & Barkley

  • Investor

    2017

    Series A investor in pain and wellness consumer products company using scientifically-formulated products

Papa & Barkley specializes in the sale and distribution of plant-based natural medicines and cannabis related products.

papaandbarkley.com

Education 

Articles About Austin

Relevant Websites